1.Effect of cerebellar intermittent theta-burst stimulation on postural control and fall risk in patients with stroke
Xinyuan LI ; Jiejiao ZHENG ; Xuejiao WU ; Linru DUAN ; Yufei GAO
Chinese Journal of Rehabilitation Theory and Practice 2026;32(5):577-587
ObjectiveTo investigate the effect of cerebellar intermittent theta-burst stimulation (iTBS) on postural control and fall risk in stroke patients. MethodsFrom October, 2024 to August, 2025, 45 stroke patients were recruited from Huadong Hospital Affiliated to Fudan University. They were randomly divided into control group (n = 15), group A (n = 15) and group B (n = 15). All the groups received conventional medication and rehabilitation. Group A was additionally administered iTBS over the ipsilesional primary motor cortex (M1), while group B received iTBS over the contralesional cerebellum, for three weeks. Before and after intervention, postural stability indexes (eyes open/closed), limits of stability, directional control score and reaction time were measured using Biodex Balance System, and they were assessed with Berg Balance Scale (BBS), Timed Up & Go Test (TUGT) and 10-meter walk test (10MWT). ResultsAfter intervention, significant group-time interaction effects were observed for eyes open/closed postural stability indexes, limits of stability, directional control score, reaction time, BBS score, TUGT and 10MWT (F > 23.487, P < 0.001). All the groups improved in all the indexes after intervention (P < 0.01). The eyes open/closed postural stability indexes, limits of stability, directional control score and reaction time were the best in group B, followed by group A, and the worst in the control group (P < 0.05), while BBS, TUGT and 10MWT were better in groups A and B than in the control group (P < 0.05). ConclusionCerebellar iTBS can effectively improve postural control disorders and reduce fall risk in stroke patients, and may be superior to M1 iTBS.
2.Clinical comprehensive evaluation of 5 kinds of biologic targeted drugs in the treatment of severe eosinophilic asthma
Yufei LIAN ; Shujuan XIONG ; Hongtao LIU ; Haijing ZHAO ; Huizhen WU
China Pharmacy 2026;37(13):1755-1761
OBJECTIVE A clinical comprehensive evaluation of five biologic targeted drugs for the treatment of severe eosinophilic asthma (SEA) was conducted to provide objective evidence for the rational selection of these medications in medical institutions. METHODS Using the evaluation methods from the Chinese Medical Institution Drug Evaluation and Selection Rapid Guide ( Third Edition ), the effectiveness, safety, pharmaceutical characteristics, cost-effectiveness, and other attributes of five biologics targeting SEA (omalizumab, mepolizumab, benralizumab, dupilumab, and tezepelumab) already marketed in China were quantitatively scored across five dimensions, and their recommendation levels were categorized based on the scores. RESULTS The comprehensive scoring results showed that mepolizumab scored 81.29, making it a highly recommended variety; benralizumab scored 78.05, dupilumab scored 77.84 and omalizumab scored 70.14,all of which are recommended varieties; tezepelumab scored 67.77, considered weakly recommended variety. CONCLUSIONS Mepolizumab shows excellent performance in eosinophil clearance, good accessibility, and is more cost-effective than the others, making it more selective in SEA treatment; omalizumab has more advantages in the treatment of SEA patients with elevated immunoglobulin E levels; dupilumab can be used as the preferred treatment for SEA patients with chronic obstructive pulmonary disease.
3.Clinical comprehensive evaluation of 5 kinds of biologic targeted drugs in the treatment of severe eosinophilic asthma
Yufei LIAN ; Shujuan XIONG ; Hongtao LIU ; Haijing ZHAO ; Huizhen WU
China Pharmacy 2026;37(13):1755-1761
OBJECTIVE A clinical comprehensive evaluation of five biologic targeted drugs for the treatment of severe eosinophilic asthma (SEA) was conducted to provide objective evidence for the rational selection of these medications in medical institutions. METHODS Using the evaluation methods from the Chinese Medical Institution Drug Evaluation and Selection Rapid Guide ( Third Edition ), the effectiveness, safety, pharmaceutical characteristics, cost-effectiveness, and other attributes of five biologics targeting SEA (omalizumab, mepolizumab, benralizumab, dupilumab, and tezepelumab) already marketed in China were quantitatively scored across five dimensions, and their recommendation levels were categorized based on the scores. RESULTS The comprehensive scoring results showed that mepolizumab scored 81.29, making it a highly recommended variety; benralizumab scored 78.05, dupilumab scored 77.84 and omalizumab scored 70.14,all of which are recommended varieties; tezepelumab scored 67.77, considered weakly recommended variety. CONCLUSIONS Mepolizumab shows excellent performance in eosinophil clearance, good accessibility, and is more cost-effective than the others, making it more selective in SEA treatment; omalizumab has more advantages in the treatment of SEA patients with elevated immunoglobulin E levels; dupilumab can be used as the preferred treatment for SEA patients with chronic obstructive pulmonary disease.
4.Phrenic Nerve Cryotherapy for Preventing Prolonged Air Leak During VATS Lobectomy.
Qingyu MENG ; Yongkun WU ; Yufei WANG ; Zhanlin GUO
Chinese Journal of Lung Cancer 2025;28(6):405-414
BACKGROUND:
Video-assisted thoracoscopic surgery (VATS) lobectomy is the primary surgical treatment for lung cancer. A significant factor affecting postoperative recovery is prolonged air leak (PAL). Despite numerous clinical strategies could prevent and manage postoperative PAL, its incidence remains high. Phrenic nerve cryotherapy (PNC) temporarily inhibits phrenic nerve function, causing diaphragm elevation, which reduces thoracic cavity volume, enhances pleural apposition, and mitigates air leakage. This study investigates the efficacy of PNC in preventing postoperative PAL during VATS lobectomy.
METHODS:
A total of 108 eligible lung cancer patients who underwent surgery at the Department of Thoracic Surgery, The Affiliated Hospital of Inner Mongolia Medical University, from June 2023 to January 2025, were enrolled and randomly assigned to the control group (n=54) and the experimental group (n=54). The patients in both the two groups received VATS lobectomy and systematic lymph node dissection, with the experimental group also undergoing PNC during the operation. The baseline characteristics, intraoperative, postoperative indicators and dynamic changes in air leakage between the two groups were compared.
RESULTS:
The baseline clinical characteristics were comparable between the two groups (P>0.05). The incidence of pulmonary air leakage at 24 h after surgery (31.5% vs 29.6%) and the incidence of postoperative PAL (20.4% vs 14.8%) showed no significant differences between the two groups (P>0.05). The intraoperative air leak test to 24 hours after surgery revealed that air leakage ceased in 8 cases (32.0%) in the control group, compared to 14 cases (46.7%) in the experimental group. Moreover, during the progression from air leakage at 24 hours post-surgery to postoperative PAL, air leakage ceased in 6 cases (35.3%) in the control group and 8 cases (50.0%) in the experimental group, with a statistically significant difference (P<0.001). Compared to the control group, the patients in the experimental group exhibited more pronounced postoperative diaphragmatic elevation that recovered to a slightly higher than preoperative level by 3 mon after surgery.
CONCLUSIONS
The combination of PNC and active lung repair can serve as an important intervention for patients at high risk of intraoperative air leakage, reducing the occurrence of postoperative PAL.
Humans
;
Thoracic Surgery, Video-Assisted/adverse effects*
;
Male
;
Female
;
Middle Aged
;
Lung Neoplasms/surgery*
;
Aged
;
Phrenic Nerve/physiopathology*
;
Cryotherapy
;
Pneumonectomy/adverse effects*
;
Postoperative Complications/etiology*
;
Adult
5.Investigation and analysis of the current status and challenges in importing rare disease drugs in China
Jingjing WU ; Qinning SU ; Xueyi TAO ; Yufei YANG ; Ningying MAO
China Pharmacy 2025;36(17):2097-2101
OBJECTIVE To analyze the current status and challenges in importing rare disease drugs in China, providing references for optimizing the import process and improving relevant policies. METHODS Questionnaires and interviews were conducted with stakeholders involved in rare disease drug importation, including government departments, multinational pharmaceutical enterprises, healthcare institutions, and patient organizations. This explored the current situation and challenges encountered by each party. Expert opinions were synthesized to propose improvement suggestions. RESULTS A questionnaire survey of representatives from 25 multinational pharmaceutical companies in the rare disease field revealed that these companies had a strong willingness to import rare disease drugs, with 58.33% of them practicing diverse import models. However, significant challenges hindered this process, including unclear regulations (54.17%), complex approval procedures (45.83%), and excessively long approval cycles (41.67%), negatively impacting their motivation. Meanwhile, interviews with 13 experts from government departments, healthcare institutions, pharmaceutical enterprises, and patient organizations identified deficiencies in policy design, approval processes, sampling inspection costs, and communication efficiency with regulators. Additionally, the drug import model in special medical zones also required improvement. CONCLUSIONS The importation of rare disease drugs in China faces challenges such as incomplete policies, inflexible regulatory mechanisms, and insufficient communication channels. It is recommended to enhance the rare disease definition criteria, optimize import incentive policies, and refine regulatory models, so as to further optimize the import process of rare disease drugs and improve relevant policies.
6.Discussion on the Treatment of Insomnia from Liver Based on the Theory "Liver Governs Wei Qi (Defensive Qi)"
Zirong LI ; Miaoran WANG ; Yufei WU ; Tian NI ; Xianbei WANG ; Hongjin DU ; Jiwei ZHANG ; Qiuyan LI
Journal of Traditional Chinese Medicine 2025;66(4):411-415
Psychological factors have become significant contributors to the onset and progression of insomnia. This article explored the treatment of insomnia from the perspective of “liver governs wei qi (defensive qi)”. The concept of “liver governs wei qi (defensive qi)” is summarized in three aspects, firstly, the liver assists the spleen and stomach in transformation and transportation, governing the generation of wei qi; secondly, the liver aids lung qi diffusion and dispersion, governing the distribution of wei qi; thirdly, the liver regulates circadian rhythms, governing the circulation of wei qi. It is proposed that the clinical treatment of insomnia should focus on the following methods: for regulating the liver to harmonize the five viscera, and facilitate the circulation of wei qi, medicinals entering the liver channel include Chaihu (Bupleuri radix), Baishao (Paeoniae Radix Alba), Zhizi (Gardeniae Fructus), and Suanzaoren (Ziziphi Spinosae Semen) could be commonly used; for nourishing the liver, the treatment should align with the day-night rhythm, and herbs such as Baihe (Lilium), Hehuan (Albizia julibrissin), and Yejiaoteng (Polygoni multiflori caulis) are commonly used; for soothing the liver and address both mental and physical health to calm wei qi, treatment should advocate verbal counseling, psychological regulation, and health education. Ultimately, this treatment approach can free liver qi to flow, soothe qi movement, restore the motion of wei qi, regulate during day and night, balance yin and yang, and resolve insomnia effectively.
7.Analysis of the demands for pharmaceutical clinic service and influential factors based on Kano model
Han SHAN ; Xuan YE ; Zihan GUO ; Jing WU ; Jinwei HU ; Xiaopei TONG ; Yufei BIN ; Jiyong LIU ; Qiong DU ; Mengmeng WANG
China Pharmacy 2025;36(22):2850-2855
OBJECTIVE To explore the characteristics and influential factors of pharmaceutical clinic service demands, providing evidence for optimizing pharmaceutical service models and facilitating pharmaceutical service models of pharmacist role transformation. METHODS A cross-sectional survey design was adopted, and 410 outpatient participants were selected from Fudan University Shanghai Cancer Center through convenience sampling for questionnaire administration from February to May 2025. Kano model was applied to analyze the demand attributes of 25 pharmaceutical services, while questionnaires were used to assess patients’ awareness and demand status. Subgroup analyses were conducted based on key demographic variables such as gender, age, educational attainment, and economic burdens, to SACA- systematically examine the differences in Kano attribute classification among patients in each subgroup. RESULTS The awareness rate of pharmaceutical outpatient services among patients was only 14.63%, yet those who were aware demonstrated a significantly higher demand rate for such services compared to those who were unaware (P<0.001). The demand for pharmaceutical clinic services exhibited a hierarchical characteristic: twelve items were identified as attractive attributes (e. g., providing suggestions for more affordable treatment options, offering online consultation services, etc.), five items as expected attributes (e.g., having a good attitude and being able to patiently answer your questions, etc.), three items as must-have attributes (e.g., providing guidance on medication dosage and usage, providing guidance on medication precautions, etc.), five items as indifferent attributes (e.g., providing treatment plan recommendations based on the patient’s condition). There were zero items classified as reverse attribute. Subgroup analysis revealed that female patients showed greater concern for “neat and clean attire of medical staff” than male patients (P<0.001); patients under 60 years of age demonstrated stronger demand for “providing treatment plan recommendations based on patients’ conditions” compared to patients aged 60 or above (P=0.016); those with below high school education placed greater emphasis on “providing guidance on medication precautions” compared to those with a high school education or above (P=0.011); patients with lower economic burdens exhibited stronger preferences for “neat and clean attire of medical staff ” (P=0.002). CONCLUSIONS The public awareness rate of pharmaceutical clinic services is considerably low; however, those who are aware of such services demonstrate significantly higher demand. The medication safety-related services and convenience-oriented demands should be prioritized in the development of pharmaceutical clinics. Moreover, the study also revealed that factors such as gender, age, educational level, and economic burdens exert significant influences on patients’ service demands.
8.Dual role of USP11 in CRC anti-tumour immunity
Yufei WU ; Yan CHEN ; Feng GUO
Journal of Clinical Surgery 2025;33(7):782-784
Colorectal cancer has a high incidence and mortality rate,and some patients do not benefit from existing treatments.Intestinal inflammation is one of the major risk factors for colorectal cancer,and an abnormal tumor immune microenvironment plays a crucial role in its occurrence and progression.As a deubiquitinating enzyme,USP11 stabilizes target proteins by removing ubiquitin molecules,thereby exerting dual roles in the antitumor immunity of colorectal cancer.USP11 enhances the specific recognition and cytotoxic function of T cells,promotes the differentiation and regulation of CD4+T cells,and induces macrophage polarization.Investigating the role and regulatory mechanisms of USP11 in colorectal cancer may provide new strategies and targets for its treatment.
9.Development and validation of a risk prediction model for tumor recurrence after breast-conserving surgery based on admission clinical data
Qinxiang WU ; Hengyi DING ; Yufei LI
Chinese Journal of General Surgery 2025;34(5):988-995
Background and Aims:Breast-conserving surgery,which balances tumor excision with preservation of breast tissue,has become a widely adopted surgical approach for breast cancer.However,postoperative tumor recurrence remains a major factor affecting patient prognosis.Accurate risk prediction tools are urgently needed to guide personalized treatment strategies.This study aimed to develop a risk prediction model for tumor recurrence after BCS based on admission clinical data and to evaluate its predictive performance to provide a scientific and practical tool for clinical decision-making.Methods:A total of 224 breast cancer patients who underwent breast-conserving surgery between May 2017 and May 2019 were enrolled.Postoperative recurrence was recorded during follow-up.Multivariate Logistic regression analysis was used to identify independent risk factors for recurrence and to construct a risk prediction model.The model's discriminative ability was assessed using the receiver operating characteristic(ROC)curve,and its calibration was evaluated using a calibration curve.Results:208 patients completed follow-up,ranging from 32 to 84 months,with a mean duration of(58.41±7.33)months.The recurrence rate was 17.79%.Multivariate Logistic regression analysis revealed that TNM stage Ⅲ(OR=2.029),tumor diameter≥4 cm(OR=1.782),≥4 lymph node metastases(OR=1.958),lymphovascular invasion(OR=1.984),and HER2 positivity(OR=1.774)were independent risk factors for recurrence(all P<0.05).The Logistic regression model was established as follows:Y=-12.788+0.707X?+0.578X?+0.672X?+0.685X?+0.573X?.The model yielded an area under the ROC curve(AUC)of 0.934(95%CI=0.891-0.963),with a sensitivity of 86.49%and specificity of 96.49%.The calibration curve demonstrated good agreement between predicted and observed outcomes(χ2=0.501,P=0.392).Conclusion:TNM stage Ⅲ,tumor diameter≥4 cm,≥4 lymph node metastases,lymphovascular invasion,and HER2 positivity are independent risk factors for tumor recurrence after breast-conserving surgery.The risk prediction model based on these factors demonstrates favorable discrimination and calibration,offering valuable guidance for postoperative risk assessment and clinical intervention.
10.Analysis of the levels and food source of cadmium exposure by dietary pathway among middle-aged and elderly populations in cadmium-contaminated areas of China
Xiaochen WANG ; Yi ZHANG ; Xiaojie DONG ; Ruiting HAO ; Xiu YE ; Wenli ZHANG ; Ying ZHU ; Ailing LIU ; Yuan WEI ; Bing WU ; Yufei LUO ; Changzi WU ; Yanning MA ; Zhengxiong YANG ; Yuebin LYU ; Gangqiang DING ; Dongqun XU ; Xiaoming SHI
Chinese Journal of Preventive Medicine 2025;59(5):597-603
Objective:To evaluate the levels and source of cadmium exposure by dietary pathway among middle-aged and elderly people ≥40 in cadmium-contaminated areas of China.Methods:A total of 7 193 people aged 40-89 years from four typical cadmium-contaminated areas in China were selected as the study subjects. Food Frequency Questionnaire (FFQ), Total Diet Study (TDS) and a 3-day-24-hour dietary recall survey were conducted. Dietary cadmium intake and food sources through dietary pathways were assessed based on cadmium content in foods, consumption amounts and intake frequencies.Results:The mean age of the participants was 63.39±12.21 years, with 50.05% being males. The average monthly dietary cadmium intake was 7.39 μg/(kg·BW). Staple foods and vegetables were the primary sources of dietary cadmium intake, accounting for 57.51% and 32.48%, respectively. The monthly dietary cadmium intake in all surveyed regions did not exceed the Provisional Tolerable Monthly Intake (PTMI) recommended by the Joint FAO/WHO Expert Committee on Food Additives (JECFA).Conclusion:The monthly dietary cadmium intake among middle-aged and elderly people in cadmium-contaminated areas of China is relatively low, with the risk remaining at an acceptable level. Staple foods and vegetables are the most significant contributors to dietary cadmium intake.

Result Analysis
Print
Save
E-mail